Somahlution, Inc Email Format

BiotechnologyFlorida, United States11-50 Employees

Somahlution, Inc. is a biotechnology research company based in Jupiter, Florida, focusing on vascular graft treatments. Its lead product, DuraGraft, is described as a treatment aimed at reducing graft failure and related complications, thereby potentially improving clinical outcomes for vascular procedures. The company serves the biomedical and surgical fields, addressing challenges associated with graft durability and postoperative complications through its proprietary technology. Somahlution operates within the biotechnology research industry and, according to available information, has a modest organizational footprint. A notable development in its history is the completion of an acquisition by Marizyme, Inc., which included Somahlution’s DuraGraft intellectual property and related assets, reflecting a shift in ownership while preserving the underlying graft-focused assets.

Get verified Somahlution, Inc emails free

Company overview Employee directory